StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.80−0.10 (-2.56%)

Close on Nov 19, 2026Market cap $92.06MP/E –Yield –

Exagen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Exagen's shares outstanding was 24M at Jun 30, 2026. For fiscal 2025 it was 22M, up 18.4% from the year before. The highest annual figure on record is 22M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202522M+18.4%
FY2024Dec 31, 202418M+3.0%
FY2023Dec 31, 202318M+3.5%
FY2022Dec 31, 202217M+7.0%
FY2021Dec 31, 202116M+26.4%
FY2020Dec 31, 202013M+253.0%
FY2019Dec 31, 20194M+5580.1%
FY2018Dec 31, 20180M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202624M+14.6%
Q1 FY2026Mar 31, 202624M+28.5%
Q4 FY2025Dec 31, 202524M+28.0%
Q3 FY2025Sep 30, 202523M+25.7%
Q2 FY2025Jun 30, 202521M+16.0%
Q1 FY2025Mar 31, 202519M+3.4%
Q4 FY2024Dec 31, 202418M+3.3%
Q3 FY2024Sep 30, 202418M+3.2%
Q2 FY2024Jun 30, 202418M+3.0%
Q1 FY2024Mar 31, 202418M+2.4%
Q4 FY2023Dec 31, 202318M+3.7%
Q3 FY2023Sep 30, 202318M+3.6%
Q2 FY2023Jun 30, 202318M+3.5%
Q1 FY2023Mar 31, 202318M+3.1%
Q4 FY2022Dec 31, 202217M+1.3%
Q3 FY2022Sep 30, 202217M+0.8%
Q2 FY2022Jun 30, 202217M+0.8%
Q1 FY2022Mar 31, 202217M+31.3%
Q4 FY2021Dec 31, 202117M+34.2%
Q3 FY2021Sep 30, 202117M+34.0%
Q2 FY2021Jun 30, 202117M+34.0%
Q1 FY2021Mar 31, 202113M+2.8%
Q4 FY2020Dec 31, 202013M+736.1%
Q3 FY2020Sep 30, 202013M+19954.5%
Q2 FY2020Jun 30, 202013M+19954.7%
Q1 FY2020Mar 31, 202013M+19891.6%
Q3 FY2019Sep 30, 20192M+2301.7%
Q2 FY2019Jun 30, 20190M–
Q1 FY2019Mar 31, 20190M–
Q4 FY2018Dec 31, 20180M–
Q3 FY2018Sep 30, 20180M–

More Exagen figures

See a number that looks wrong?